Research

We have four important clinical trials at Retina Associates of Florida. We are enrolling patients in the following studies:

WET AMD:
Fovista trial(Ophthotech)
COMPARES : Lucentis (Anti-VEGF) + Fovista (Anti-PDGF) vs Lucentis monotherapy
ELIGIBILITY : Patients will be randomized to combination therapy vs monotherapy for newly diagnosed Wet AMD with vision of 20/32 – 20/300.
DURATION : 12 months
QUESTION : Does combination treatment result in better vision and less scarring?

DRY AMD:
Lampalizumab trial(Genentech/Roche)
COMPARES : Lampalizumab vs control
ELIGIBILITY : Patients with areas of geographic atrophy and good visual acuity
DURATION : 12 months
QUESTION : Does lampalizumab reduce rate of vision loss and progression? Is there a genetic subtype that has better outcome?

The trials are sponsored, so eligible patients will not incur additional costs. We encourage you to refer eligible patients as they would benefit from the studies and help us answer important questions.

Dr. Suñer’s Blog

Clinical Trials Currently Enrolling

Learn about RAF's Clinical Trials.

New RAF Brandon Office

Retina Associates is now seeing patients on Wednesday afternoons at its new Brandon location. Click here for the address and to make an appointment.

800-282-9141

DIABETIC RETINOPATHY:
DRCR Protocol U trial
COMPARES : Lucentis (Anti-VEGF) + Dexamethasone (steroid) vs Lucentis alone ELIGIBILITY : Patients will be randomized to combination therapy vs monotherapy for recurrent diabetic macular edema and at least 6 previous injections of Anti-VEGF with vision of 20/30 – 20/300. Patients must have had previous cataract surgery.
DURATION : 12 months
QUESTION : Which treatment is best for preserving good visual acuity?

DRCR Protocol V trial
COMPARES : macular laser + Lucentis vs Prompt Lucentis (Anti-VEGF) vs Observation and deferred Lucentis
ELIGIBILITY : New diagnosis of diabetic macular with vision of 20/25 or better.
DURATION : 2 years
QUESTION :: Which treatment is best for preserving good visual acuity?